Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic susceptibility to thrombosis.

James P Luyendyk1, Rachel E Tilley, Nigel Mackman

  • 1Department of Immunology, The Scripps Research Institute, 10550 North Torrey Pines Road, CVN-18, La Jolla, CA 92037, USA.

Current Atherosclerosis Reports
|April 28, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-fibrinolytic strategies improve liver regeneration in mice and reduce post-hepatectomy liver failure in patients.

Blood·2026
Same author

Visualization of intrahepatic activation of coagulation and its contribution to disease progression in mice with acetaminophen-induced acute liver injury.

Journal of thrombosis and haemostasis : JTH·2026
Same author

One Health horsepower in hemostasis: SEL1Lecting stable platelet adhesion.

The Journal of clinical investigation·2026
Same author

Silencing of PAI-1 using siRNA-lipid nanoparticles reduces thrombosis and prolongs life span in murine models.

Blood·2026
Same author

Urokinase Plasminogen Activator Deficiency Delays the Development of Obesity and Metabolic Sequelae.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same author

Role of the Plasminogen Activation System in Liver Injury and Repair: Knowns and Known Unknowns.

Arteriosclerosis, thrombosis, and vascular biology·2025
Same journal

Overview of Novel Mechanisms in Obesity Pharmacotherapy and Implications for Cardiovascular Disease: A Narrative Review.

Current atherosclerosis reports·2026
Same journal

Artificial and Other Non-Nutritive Sweeteners, the Microbiome, and Cardiometabolic Health.

Current atherosclerosis reports·2026
Same journal

Single-cell Technologies in Atherosclerosis: Uncovering Cellular Heterogeneity, Mechanisms, and Therapeutic Opportunities.

Current atherosclerosis reports·2026
Same journal

Primary Prevention of Dyslipidemia: 10 Practice-Changing Takeaways from the 2026 ACC/AHA Multisociety Guideline.

Current atherosclerosis reports·2026
Same journal

Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.

Current atherosclerosis reports·2026
Same journal

Familial Hypercholesterolemia in Women: Diagnosis, Treatment, and Cardiovascular Outcomes Across the Lifespan.

Current atherosclerosis reports·2026
See all related articles

Thrombosis, a condition linked to inflammation and cardiovascular events, is influenced by genetic and environmental factors. This review explores how variations in tissue factor gene (coagulation initiator) impact thrombosis risk.

Area of Science:

  • Cardiovascular Biology
  • Hematology
  • Genetics

Background:

  • Thrombosis is a significant cause of morbidity and mortality, linked to inflammatory conditions like atherosclerosis, sepsis, and cancer.
  • Complications include myocardial infarction, stroke, and venous thromboembolism.
  • Both genetic predisposition and environmental influences contribute to thrombosis risk.

Purpose of the Study:

  • To review the association between genetic polymorphisms and the risk of developing thrombosis.
  • To highlight the role of tissue factor as a key initiator of coagulation in thrombotic events.

Main Methods:

  • Literature review focusing on genetic polymorphisms.
  • Analysis of studies investigating the link between specific gene variations and thrombosis.

Related Experiment Videos

  • Examination of the role of tissue factor in coagulation pathways.

    • Main Results:

    • Various polymorphisms have been identified that correlate with altered thrombosis susceptibility.
    • Tissue factor (TF) is confirmed as a critical initiator of the extrinsic coagulation cascade.
    • Specific TF gene variations may influence an individual's risk for thrombotic diseases.

    Conclusions:

    • Genetic variations, particularly in the tissue factor pathway, play a role in thrombosis risk.
    • Understanding these genetic factors is crucial for predicting and potentially preventing thrombotic events.
    • Further research into gene-environment interactions is warranted for comprehensive risk assessment.